Exicure (XCUR) Return on Sales [ROS] (2016 - 2024)
Exicure's Return on Sales [ROS] was -2446.40% in Q4 2024, down 1218.20 percentage points from the prior quarter.
Powered by 
Analysis
Exicure (XCUR) Return on Sales [ROS] (2016 - 2024) Analysis & Trends
From Q4 2016 onward, Exicure has reported Return on Sales [ROS] for 31 quarters.
- Return on Sales [ROS] shows a five-year change of -392.62 percentage points (FY2019 to FY2024).
- In earlier years, Return on Sales [ROS] was -6.35% in FY2022 (+12943.75 pp), -12950.10% in FY2021 (-12796.99 pp) and -153.11% in FY2020 (+1900.67 pp).
- The Q4 2024 figure marks the lowest quarterly Return on Sales [ROS] since Q2 2021.
- Compared with a year earlier, Return on Sales [ROS] was higher in three of the last six quarters, with an average year-over-year change of -318.32 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q1 2020 (a gain of 22317.82 percentage points); the worst was Q2 2021 (a drop of 17456.26 percentage points).
- Per Business Quant data, XCUR's Return on Sales [ROS] in the three quarters before Q4 2024 was -1228.20% (Q3 2024), -1377.20% (Q2 2024) and -167.20% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Exicure | 7.39 Mn | 7.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -2,446.40% |
| Sep 30, 2024 | -1,228.20% |
| Jun 30, 2024 | -1,377.20% |
| Mar 31, 2024 | -167.20% |
| Sep 30, 2023 | 23.40% |
| Jun 30, 2023 | 13.48% |
| Mar 31, 2023 | 5.21% |
| Dec 31, 2022 | 85.40% |
| Sep 30, 2022 | -258.18% |
| Jun 30, 2022 | -302.83% |
| Mar 31, 2022 | -301.64% |
| Dec 31, 2021 | -2,373.78% |
| Sep 30, 2021 | -627.71% |
| Jun 30, 2021 | -17,546.84% |
| Mar 31, 2021 | -1,219.36% |
| Dec 31, 2020 | -8,900.00% |
| Sep 30, 2020 | -373.31% |
| Jun 30, 2020 | -90.57% |
| Mar 31, 2020 | 5.82% |
| Dec 31, 2019 | -3,260.97% |
API Access
Exicure Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XCUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XCUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XCUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();